TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62399429
log Bayes Factor = 22.6436
Chromosome 6   position 30,993,813  (GRCh37) Explore rs62399429 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
R31 Unspecified haematuria
0.917 0.083 0.000
K90 Intestinal malabsorption
0.000 0.295 0.705
K90.9 Intestinal malabsorption, unspecified
0.000 0.383 0.617
M45.X9 Ankylosing spondylitis (Site unspecified)
0.570 0.430 0.000
K90.8 Other intestinal malabsorption
0.000 0.487 0.512
K90.3 Pancreatic steatorrhoea
0.000 0.494 0.506
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.494 0.506
K90.1 Tropical sprue
0.000 0.494 0.506
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.499 0.500
M45 Ankylosing spondylitis
0.399 0.601 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.337 0.663 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.315 0.685 0.000
M45.X2 Ankylosing spondylitis (Cervical region)
0.305 0.695 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.286 0.714 0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.286 0.714 0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.286 0.714 0.000
M45.X4 Ankylosing spondylitis (Thoracic region)
0.286 0.714 0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.286 0.714 0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.286 0.714 0.000
K90-K93 Other diseases of the digestive system
0.000 0.778 0.222
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.809 0.191
K91.3 Postoperative intestinal obstruction
0.000 0.820 0.180
D86.9 Sarcoidosis, unspecified
0.000 0.821 0.179
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.832 0.168
D86 Sarcoidosis
0.000 0.833 0.167
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.840 0.160
K91.1 Postgastric surgery syndromes
0.000 0.852 0.148
D86.0 Sarcoidosis of lung
0.000 0.854 0.146
D86.8 Sarcoidosis of other and combined sites
0.000 0.854 0.145
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.145 0.855 0.000
D86.1 Sarcoidosis of lymph nodes
0.000 0.859 0.141
K91.5 Postcholecystectomy syndrome
0.000 0.863 0.137
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.863 0.137
L40.9 Psoriasis, unspecified
0.000 0.864 0.136
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.129 0.871 0.000
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.880 0.120
D86.3 Sarcoidosis of skin
0.000 0.880 0.120
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.880 0.120
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.885 0.115
K93.1 Megacolon in Chagas' disease
0.000 0.885 0.115
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.885 0.115
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.885 0.114
C82.3 Follicular lymphoma grade IIIa
0.110 0.890 0.000
C82.4 Follicular lymphoma grade IIIb
0.109 0.891 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.103 0.897 0.000
C82.0 Small cleaved cell, follicular
0.098 0.902 0.000
C82.6 Cutaneous follicle centre lymphoma
0.092 0.907 0.000
C82.5 Diffuse follicle centre lymphoma
0.092 0.907 0.000
C82.2 Large cell, follicular
0.092 0.907 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.091 0.908 0.000
D80-D89 Certain disorders involving the immune mechanism
0.000 0.910 0.090
D80 Immunodeficiency with predominantly antibody defects
0.000 0.924 0.076
D80.1 Nonfamilial hypogammaglobulinaemia
0.000 0.933 0.067
D82 Immunodeficiency associated with other major defects
0.000 0.935 0.065
D81 Combined immunodeficiencies
0.000 0.935 0.065
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.063 0.937 0.000
D83 Common variable immunodeficiency
0.000 0.938 0.062
L40 Psoriasis
0.000 0.938 0.061
C81 Hodgkin's disease
0.060 0.940 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.060 0.940 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.000 0.942 0.057
T42.4 Benzodiazepines
0.056 0.944 0.000
L40.0 Psoriasis vulgaris
0.000 0.945 0.055
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.000 0.945 0.055
D80.8 Other immunodeficiencies with predominantly antibody defects
0.000 0.945 0.055
D80.7 Transient hypogammaglobulinaemia of infancy
0.000 0.945 0.055
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.000 0.945 0.055
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.000 0.945 0.055
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.000 0.945 0.055
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.000 0.945 0.055
D80.0 Hereditary hypogammaglobulinaemia
0.000 0.945 0.055
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.054 0.946 0.000
C83.3 Large cell (diffuse)
0.054 0.946 0.000
C81.9 Hodgkin's disease, unspecified
0.053 0.947 0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.000 0.948 0.052
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.051 0.949 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.051 0.949 0.000
C81.0 Lymphocytic predominance
0.050 0.949 0.000
D84 Other immunodeficiencies
0.000 0.950 0.050
C84 Peripheral and cutaneous T-cell lymphomas
0.050 0.950 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.049 0.950 0.000
C81.7 Other Hodgkin's disease
0.047 0.953 0.000
D81.9 Combined immunodeficiency, unspecified
0.000 0.953 0.046
D81.8 Other combined immunodeficiencies
0.000 0.953 0.046
D81.7 Major histocompatibility complex class II deficiency
0.000 0.953 0.046
D81.6 Major histocompatibility complex class I deficiency
0.000 0.953 0.046
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.000 0.953 0.046
D81.4 Nezelof's syndrome
0.000 0.953 0.046
D81.3 Adenosine deaminase [ADA] deficiency
0.000 0.953 0.046
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.000 0.953 0.046
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.000 0.953 0.046
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.000 0.953 0.046
D82.9 Immunodeficiency associated with major defect, unspecified
0.000 0.953 0.046
D82.8 Immunodeficiency associated with other specified major defects
0.000 0.953 0.046
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.000 0.953 0.046
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.000 0.953 0.046
D82.2 Immunodeficiency with short-limbed stature
0.000 0.953 0.046
D82.1 Di George's syndrome
0.000 0.953 0.046
D82.0 Wiskott-Aldrich syndrome
0.000 0.953 0.046
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.000 0.953 0.047
C81.2 Mixed cellularity
0.046 0.954 0.000
C83.1 Small cleaved cell (diffuse)
0.046 0.954 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.045 0.954 0.000
C94 Other leukaemias of specified cell type
0.045 0.954 0.000
C93 Monocytic leukaemia
0.045 0.954 0.000
C86 Other specified types of T/NK-cell lymphoma
0.045 0.954 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.045 0.955 0.000
C81.1 Nodular sclerosis
0.045 0.955 0.000
C83.7 Burkitt's tumour
0.045 0.955 0.000
D51 Vitamin B12 deficiency anaemia
0.000 0.955 0.045
D83.8 Other common variable immunodeficiencies
0.000 0.955 0.044
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.000 0.955 0.044
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.000 0.955 0.044
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.000 0.955 0.044
L40.4 Guttate psoriasis
0.000 0.956 0.044
L40.3 Pustulosis palmaris et plantaris
0.000 0.956 0.044
L40.2 Acrodermatitis continua
0.000 0.956 0.044
L40.1 Generalised pustular psoriasis
0.000 0.956 0.044
C95 Leukaemia of unspecified cell type
0.044 0.956 0.000
D50-D53 Nutritional anaemias
0.000 0.956 0.044
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.956 0.044
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.043 0.956 0.000
C81.3 Lymphocytic depletion
0.043 0.956 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.043 0.957 0.000
C83.6 Undifferentiated (diffuse)
0.043 0.957 0.000
C83.5 Lymphoblastic (diffuse)
0.043 0.957 0.000
C83.4 Immunoblastic (diffuse)
0.043 0.957 0.000
C83.2 Mixed small and large cell (diffuse)
0.043 0.957 0.000
T42.0 Hydantoin derivatives
0.043 0.957 0.000
M45-M49 Spondylopathies
0.042 0.958 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.000 0.958 0.041
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.000 0.958 0.041
D89.3 Immune reconstitution syndrome
0.000 0.958 0.041
D83.9 Common variable immunodeficiency, unspecified
0.000 0.959 0.041
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.041 0.959 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.040 0.960 0.000
D60-D64 Aplastic and other anaemias
0.000 0.960 0.040
D89.2 Hypergammaglobulinaemia, unspecified
0.000 0.960 0.040
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.000 0.960 0.040
D89.1 Cryoglobulinaemia
0.000 0.960 0.039
C88 Malignant immunoproliferative diseases
0.039 0.961 0.000
J47 Bronchiectasis
0.039 0.961 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.039 0.961 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.039 0.961 0.000
T42.3 Barbiturates
0.039 0.961 0.000
T42.2 Succinimides and oxazolidinediones
0.039 0.961 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.039 0.961 0.000
C84.5 Other and unspecified T-cell lymphomas
0.039 0.961 0.000
L40.8 Other psoriasis
0.000 0.961 0.039
D89.0 Polyclonal hypergammaglobulinaemia
0.000 0.962 0.038
C84.0 Mycosis fungoides
0.038 0.962 0.000
D64 Other anaemias
0.000 0.963 0.037
T42.1 Iminostilbenes
0.037 0.963 0.000
D84.8 Other specified immunodeficiencies
0.000 0.964 0.036
D84.1 Defects in the complement system
0.000 0.964 0.036
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.000 0.964 0.036
C84.9 Mature T/NK-cell lymphoma, unspecified
0.036 0.964 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.036 0.964 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.036 0.964 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.036 0.964 0.000
C84.3 Lymphoepithelioid lymphoma
0.036 0.964 0.000
C84.2 T-zone lymphoma
0.036 0.964 0.000
C84.1 Sezary's diease
0.036 0.964 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.036 0.964 0.000
D64.9 Anaemia, unspecified
0.000 0.964 0.036
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.036 0.964 0.000
T45.5 Anticoagulants
0.035 0.965 0.000
C84.4 Peripheral T-cell lymphoma
0.035 0.965 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.034 0.966 0.000
K91.4 Colostomy and enterostomy malfunction
0.000 0.967 0.033
D53 Other nutritional anaemias
0.000 0.967 0.033
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.033 0.967 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.033 0.967 0.000
C86.4 Blastic NK-cell lymphoma
0.033 0.967 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.033 0.967 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.033 0.967 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.033 0.967 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.033 0.967 0.000
C93.9 Monocytic leukaemia, unspecified
0.033 0.967 0.000
C93.7 Other monocytic leukaemia
0.033 0.967 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.033 0.967 0.000
C93.2 Subacute monocytic leukaemia
0.033 0.967 0.000
C93.1 Chronic monocytic leukaemia
0.033 0.967 0.000
C93.0 Acute monocytic leukaemia
0.033 0.967 0.000
C94.7 Other specified leukaemias
0.033 0.967 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.033 0.967 0.000
C94.5 Acute myelofibrosis
0.033 0.967 0.000
C94.4 Acute panmyelosis
0.033 0.967 0.000
C94.3 Mast cell leukaemia
0.033 0.967 0.000
C94.2 Acute megakaryoblastic leukaemia
0.033 0.967 0.000
C94.1 Chronic erythraemia
0.033 0.967 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.033 0.967 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.033 0.967 0.000
C96.8 Histiocytic sarcoma
0.033 0.967 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.033 0.967 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.033 0.967 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.033 0.967 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.033 0.967 0.000
C96.3 True histiocytic lymphoma
0.033 0.967 0.000
C96.2 Malignant mast cell tumour
0.033 0.967 0.000
C96.1 Malignant histiocytosis
0.033 0.967 0.000
C96.0 Letterer-Siwe disease
0.033 0.967 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.033 0.967 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.033 0.967 0.000
C85.0 Lymphosarcoma
0.033 0.967 0.000
D51.8 Other vitamin B12 deficiency anaemias
0.000 0.968 0.032
D51.3 Other dietary vitamin B12 deficiency anaemia
0.000 0.968 0.032
D51.2 Transcobalamin II deficiency
0.000 0.968 0.032
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.000 0.968 0.032
T36 Poisoning by systemic antibiotics
0.032 0.968 0.000
C95.7 Other leukaemia of unspecified cell type
0.032 0.968 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.032 0.968 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.032 0.968 0.000
C95.0 Acute leukaemia of unspecified cell type
0.032 0.968 0.000
D62 Acute posthaemorrhagic anaemia
0.000 0.968 0.032
T46 Poisoning by agents primarily affecting the cardiovascular system
0.032 0.968 0.000
M46 Other inflammatory spondylopathies
0.031 0.969 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.031 0.969 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.031 0.969 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.031 0.969 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.031 0.969 0.000
T45.0 Antiallergic and antiemetic drugs
0.031 0.969 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.031 0.969 0.000
J40 Bronchitis, not specified as acute or chronic
0.031 0.969 0.000
C95.9 Leukaemia, unspecified
0.030 0.969 0.000
T43.2 Other and unspecified antidepressants
0.031 0.969 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.030 0.970 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.029 0.971 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.029 0.971 0.000
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.000 0.971 0.029
D52 Folate deficiency anaemia
0.000 0.971 0.029
D55-D59 Haemolytic anaemias
0.000 0.971 0.029
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.029 0.971 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.028 0.972 0.000
C88.7 Other malignant immunoproliferative diseases
0.028 0.972 0.000
C88.3 Immunoproliferative small intestinal disease
0.028 0.972 0.000
C88.2 Gamma heavy chain disease
0.028 0.972 0.000
C88.1 Alpha heavy chain disease
0.028 0.972 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.028 0.972 0.000
T45.8 Other primarily systemic and haematological agents
0.028 0.972 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.028 0.972 0.000
T45.6 Fibrinolysis-affecting drugs
0.028 0.972 0.000
T45.4 Iron and its compounds
0.028 0.972 0.000
T45.3 Enzymes, not elsewhere classified
0.028 0.972 0.000
T45.2 Vitamins, not elsewhere classified
0.028 0.972 0.000
M49 Spondylopathies in diseases classified elsewhere
0.028 0.972 0.000
T43.6 Psychostimulants with abuse potential
0.028 0.972 0.000
K92 Other diseases of digestive system
0.000 0.972 0.028
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.028 0.972 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.027 0.972 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.028 0.972 0.000
T38.1 Thyroid hormones and substitutes
0.027 0.973 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.027 0.973 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.000 0.973 0.027
D64.4 Congenital dyserythropoietic anaemia
0.000 0.973 0.027
D64.3 Other sideroblastic anaemias
0.000 0.973 0.027
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
0.000 0.973 0.027
D64.1 Secondary sideroblastic anaemia due to disease
0.000 0.973 0.027
D64.0 Hereditary sideroblastic anaemia
0.000 0.973 0.027
D64.8 Other specified anaemias
0.000 0.973 0.027
L40.5 Arthropathic psoriasis
0.000 0.973 0.027
C90 Multiple myeloma and malignant plasma cell neoplasms
0.026 0.973 0.001
C83.0 Small cell (diffuse)
0.026 0.974 0.000
D61 Other aplastic anaemias
0.000 0.974 0.026
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.026 0.974 0.000
T50.8 Diagnostic agents
0.026 0.974 0.000
T50.7 Analeptics and opioid receptor antagonists
0.026 0.974 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.026 0.974 0.000
T50.5 Appetite depressants
0.026 0.974 0.000
T50.4 Drugs affecting uric acid metabolism
0.026 0.974 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.026 0.974 0.000
T50.1 Loop [high-ceiling] diuretics
0.026 0.974 0.000
T50.0 Mineralocorticoids and their antagonists
0.026 0.974 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.026 0.974 0.000
T43.9 Psychotropic drug, unspecified
0.026 0.974 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.026 0.974 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.026 0.974 0.000
D53.9 Nutritional anaemia, unspecified
0.000 0.974 0.026
Z87.8 Personal history of other specified conditions
0.000 0.975 0.025
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.025 0.975 0.000
M46.9 Inflammatory spondylopathy, unspecified
0.025 0.975 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.024 0.975 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.024 0.975 0.000
T47.7 Emetics
0.024 0.975 0.000
T47.6 Antidiarrhoeal drugs
0.024 0.975 0.000
T47.5 Digestants
0.024 0.975 0.000
T47.4 Other laxatives
0.024 0.975 0.000
T47.3 Saline and osmotic laxatives
0.024 0.975 0.000
T47.2 Stimulant laxatives
0.024 0.975 0.000
T47.0 Histamine H(2)-receptor antagonists
0.024 0.975 0.000
D53.8 Other specified nutritional anaemias
0.000 0.976 0.024
D53.2 Scorbutic anaemia
0.000 0.976 0.024
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.000 0.976 0.024
D53.0 Protein deficiency anaemia
0.000 0.976 0.024
T36.0 Penicillins
0.024 0.976 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.024 0.976 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.024 0.976 0.000
T38.9 Other and unspecified hormone antagonists
0.024 0.976 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.024 0.976 0.000
T38.7 Androgens and anabolic congeners
0.024 0.976 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.024 0.976 0.000
T38.5 Other oestrogens and progestogens
0.024 0.976 0.000
T38.4 Oral contraceptives
0.024 0.976 0.000
T38.2 Antithyroid drugs
0.024 0.976 0.000
T38.0 Glucocorticoids and synthetic analogues
0.024 0.976 0.000
T36.9 Systemic antibiotic, unspecified
0.023 0.977 0.000
T36.8 Other systemic antibiotics
0.023 0.977 0.000
T36.7 Antifungal antibiotics, systemically used
0.023 0.977 0.000
T36.6 Rifamycins
0.023 0.977 0.000
T36.5 Aminoglycosides
0.023 0.977 0.000
T36.4 Tetracyclines
0.023 0.977 0.000
T36.3 Macrolides
0.023 0.977 0.000
T36.2 Chloramphenicol group
0.023 0.977 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.023 0.977 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.023 0.977 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.023 0.977 0.000
T46.7 Peripheral vasodilators
0.023 0.977 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.023 0.977 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.023 0.977 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.023 0.977 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.022 0.977 0.000
M46.8 Other specified inflammatory spondylopathies
0.023 0.977 0.000
M46.5 Other infective spondylopathies
0.023 0.977 0.000
M46.3 Infection of intervertebral disk (pyogenic)
0.023 0.977 0.000
M46.2 Osteomyelitis of vertebra
0.023 0.977 0.000
M46.0 Spinal enthesopathy
0.023 0.977 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.023 0.977 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.023 0.977 0.000
T37.5 Antiviral drugs
0.023 0.977 0.000
T37.4 Anthelminthics
0.023 0.977 0.000
T37.3 Other antiprotozoal drugs
0.023 0.977 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.023 0.977 0.000
T37.1 Antimycobacterial drugs
0.023 0.977 0.000
T37.0 Sulphonamides
0.023 0.977 0.000
T41.5 Therapeutic gases
0.023 0.977 0.000
T41.4 Anaesthetic, unspecified
0.023 0.977 0.000
T41.3 Local anaesthetics
0.023 0.977 0.000
T41.2 Other and unspecified general anaesthetics
0.023 0.977 0.000
T41.1 Intravenous anaesthetics
0.023 0.977 0.000
T41.0 Inhaled anaesthetics
0.023 0.977 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.023 0.977 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.023 0.977 0.000
T48.5 Anti-common-cold drugs
0.023 0.977 0.000
T48.4 Expectorants
0.023 0.977 0.000
T48.3 Antitussives
0.023 0.977 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.023 0.977 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.023 0.977 0.000
T48.0 Oxytocic drugs
0.023 0.977 0.000
T49.9 Topical agent, unspecified
0.023 0.977 0.000
T49.8 Other topical agents
0.023 0.977 0.000
T49.7 Dental drugs, topically applied
0.023 0.977 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.023 0.977 0.000
T49.5 Ophthalmological drugs and preparations
0.023 0.977 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.023 0.977 0.000
T49.3 Emollients, demulcents and protectants
0.023 0.977 0.000
T49.2 Local astringents and local detergents
0.023 0.977 0.000
T49.1 Antipruritics
0.023 0.977 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.023 0.977 0.000
D69 Purpura and other haemorrhagic conditions
0.000 0.977 0.023
M46.1 Sacro-iliitis, not elsewhere classified
0.022 0.977 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.000 0.978 0.022
T39.0 Salicylates
0.022 0.978 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.022 0.978 0.000
Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue
0.000 0.978 0.022
D84.9 Immunodeficiency, unspecified
0.001 0.978 0.021
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.022 0.978 0.000
T39.4 Antirheumatics, not elsewhere classified
0.022 0.978 0.000
T39.2 Pyrazolone derivatives
0.022 0.978 0.000
T40.4 Other synthetic narcotics
0.022 0.978 0.000
M46.4 Discitis, unspecified
0.021 0.979 0.000
C92 Myeloid leukaemia
0.021 0.979 0.001
D60.9 Acquired pure red cell aplasia, unspecified
0.000 0.979 0.021
D60.8 Other acquired pure red cell aplasias
0.000 0.979 0.021
D60.1 Transient acquired pure red cell aplasia
0.000 0.979 0.021
D60.0 Chronic acquired pure red cell aplasia
0.000 0.979 0.021
D58 Other hereditary haemolytic anaemias
0.000 0.979 0.021
T46.1 Calcium-channel blockers
0.021 0.979 0.000
D52.8 Other folate deficiency anaemias
0.000 0.979 0.021
D52.1 Drug-induced folate deficiency anaemia
0.000 0.979 0.021
D52.0 Dietary folate deficiency anaemia
0.000 0.979 0.021
D57 Sickle-cell disorders
0.000 0.979 0.021
D55 Anaemia due to enzyme disorders
0.000 0.979 0.021
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.021 0.979 0.000
T40.8 Lysergide [LSD]
0.021 0.979 0.000
T40.7 Cannabis (derivatives)
0.021 0.979 0.000
T40.5 Cocaine
0.021 0.979 0.000
T40.3 Methadone
0.021 0.979 0.000
T40.1 Heroin
0.021 0.979 0.000
T40.0 Opium
0.021 0.979 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.021 0.979 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.000 0.979 0.020
M49.8 Spondylopathy in other diseases classified elsewhere
0.020 0.980 0.000
M49.4 Neuropathic spondylopathy
0.020 0.980 0.000
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere
0.020 0.980 0.000
M49.2 Enterobacterial spondylitis
0.020 0.980 0.000
M49.1 Brucella spondylitis
0.020 0.980 0.000
M49.0 Tuberculosis of spine
0.020 0.980 0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities
0.000 0.980 0.020
T43.0 Tricyclic and tetracyclic antidepressants
0.020 0.980 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.020 0.980 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.020 0.980 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.020 0.980 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.020 0.980 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.020 0.980 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.020 0.980 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.020 0.980 0.000
T44.0 Anticholinesterase agents
0.020 0.980 0.000
D69.6 Thrombocytopenia, unspecified
0.000 0.980 0.020
J40-J47 Chronic lower respiratory diseases
0.020 0.980 0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)
0.020 0.980 0.000
D59 Acquired haemolytic anaemia
0.000 0.980 0.020
M47.92 Spondylosis, unspecified (Cervical region)
0.000 0.980 0.020
D67 Hereditary factor IX deficiency
0.000 0.980 0.020
T46.4 Angiotensin-converting-enzyme inhibitors
0.020 0.980 0.000
Z87 Personal history of other diseases and conditions
0.000 0.980 0.020
T40.2 Other opioids
0.019 0.981 0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)
0.019 0.981 0.000
C90.3 Solitary plasmacytoma
0.019 0.981 0.001
C90.1 Plasma cell leukaemia
0.019 0.981 0.001
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.019 0.981 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.019 0.981 0.000
D61.8 Other specified aplastic anaemias
0.000 0.981 0.019
D61.3 Idiopathic aplastic anaemia
0.000 0.981 0.019
D61.2 Aplastic anaemia due to other external agents
0.000 0.981 0.019
D61.0 Constitutional aplastic anaemia
0.000 0.981 0.019
D50 Iron deficiency anaemia
0.000 0.981 0.019
D69.3 Idiopathic thrombocytopenic purpura
0.000 0.981 0.019
D66 Hereditary factor VIII deficiency
0.000 0.981 0.019
T40.6 Other and unspecified narcotics
0.018 0.981 0.000
T39.1 4-Aminophenol derivatives
0.018 0.982 0.000
D61.1 Drug-induced aplastic anaemia
0.000 0.982 0.018
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.018 0.982 0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue
0.000 0.982 0.018
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.018 0.982 0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)
0.018 0.982 0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)
0.018 0.982 0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)
0.018 0.982 0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)
0.018 0.982 0.000
M49.5 Collapsed vertebra in diseases classified elsewhere
0.018 0.982 0.000
M48 Other spondylopathies
0.018 0.982 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.018 0.982 0.000
D52.9 Folate deficiency anaemia, unspecified
0.000 0.982 0.018
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)
0.018 0.982 0.000
C90.2 Plasmacytoma, extramedullary
0.017 0.982 0.001
D63.8 Anaemia in other chronic diseases classified elsewhere
0.000 0.983 0.017
D61.9 Aplastic anaemia, unspecified
0.000 0.983 0.017
D69.5 Secondary thrombocytopenia
0.000 0.983 0.017
C85.1 B-cell lymphoma, unspecified
0.017 0.983 0.000
M47.9 Spondylosis, unspecified
0.000 0.983 0.017
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)
0.017 0.983 0.000
D56 Thalassaemia
0.000 0.983 0.016
D58.0 Hereditary spherocytosis
0.000 0.983 0.017
K92.1 Melaena
0.000 0.983 0.017
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.000 0.983 0.017
M46.09 Spinal enthesopathy (Site unspecified)
0.016 0.983 0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)
0.016 0.983 0.000
M46.07 Spinal enthesopathy (Lumbosacral region)
0.016 0.983 0.000
M46.06 Spinal enthesopathy (Lumbar region)
0.016 0.983 0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)
0.016 0.983 0.000
M46.04 Spinal enthesopathy (Thoracic region)
0.016 0.983 0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)
0.016 0.983 0.000
M46.02 Spinal enthesopathy (Cervical region)
0.016 0.983 0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)
0.016 0.983 0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)
0.016 0.983 0.000
M46.29 Osteomyelitis of vertebra (Site unspecified)
0.016 0.983 0.000
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)
0.016 0.983 0.000
M46.27 Osteomyelitis of vertebra (Lumbosacral region)
0.016 0.983 0.000
M46.26 Osteomyelitis of vertebra (Lumbar region)
0.016 0.983 0.000
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)
0.016 0.983 0.000
M46.24 Osteomyelitis of vertebra (Thoracic region)
0.016 0.983 0.000
M46.23 Osteomyelitis of vertebra (Cervicothoracic region)
0.016 0.983 0.000
M46.22 Osteomyelitis of vertebra (Cervical region)
0.016 0.983 0.000
M46.21 Osteomyelitis of vertebra (Occipito-atlanto-axial region)
0.016 0.983 0.000
M46.20 Osteomyelitis of vertebra (Multiple sites in spine)
0.016 0.983 0.000
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)
0.016 0.983 0.000
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)
0.016 0.983 0.000
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)
0.016 0.983 0.000
M46.36 Infection of intervertebral disc (pyogenic) (Lumbar region)
0.016 0.983 0.000
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)
0.016 0.983 0.000
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)
0.016 0.983 0.000
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)
0.016 0.983 0.000
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)
0.016 0.983 0.000
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)
0.016 0.983 0.000
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)
0.016 0.983 0.000
M46.59 Other infective spondylopathies (Site unspecified)
0.016 0.983 0.000
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)
0.016 0.983 0.000
M46.57 Other infective spondylopathies (Lumbosacral region)
0.016 0.983 0.000
M46.56 Other infective spondylopathies (Lumbar region)
0.016 0.983 0.000
M46.55 Other infective spondylopathies (Thoracolumbar region)
0.016 0.983 0.000
M46.54 Other infective spondylopathies (Thoracic region)
0.016 0.983 0.000
M46.53 Other infective spondylopathies (Cervicothoracic region)
0.016 0.983 0.000
M46.52 Other infective spondylopathies (Cervical region)
0.016 0.983 0.000
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)
0.016 0.983 0.000
M46.50 Other infective spondylopathies (Multiple sites in spine)
0.016 0.983 0.000
M46.89 Other specified inflammatory spondylopathies (Site unspecified)
0.016 0.983 0.000
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)
0.016 0.983 0.000
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)
0.016 0.983 0.000
M46.86 Other specified inflammatory spondylopathies (Lumbar region)
0.016 0.983 0.000
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)
0.016 0.983 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.